Neurocrine Bioscience buy Royal Bank of Canada
Start price
31.07.25
/
50%
€112.45
Target price
31.07.26
€125.97
Performance (%)
-1.78%
Price
12.08.25
€110.45
Summary
This prediction is currently active. With a performance of -1.78%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 31.07.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -0.451% |
| iShares Core DAX® | 1.061% |
| iShares Nasdaq 100 | 2.615% |
| iShares Nikkei 225® | 5.693% |
| iShares S&P 500 | 1.433% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at Royal Bank Of Canada from $146.00 to $144.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.85
02.06.25
02.06.25
€127.53
02.06.26
02.06.26
1.47%
12.08.25
12.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€128.38
06.05.26
06.05.26
4.30%
12.08.25
12.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€83.38
14.04.25
14.04.25
€120.31
14.04.26
14.04.26
32.47%
12.08.25
12.08.25